Annual CFO
-$172.58 M
-$91.22 M-112.11%
November 30, 2024
Summary
- As of February 8, 2025, NRIX annual cash flow from operations is -$172.58 million, with the most recent change of -$91.22 million (-112.11%) on November 30, 2024.
- During the last 3 years, NRIX annual CFO has fallen by -$88.22 million (-104.57%).
- NRIX annual CFO is now -28816.14% below its all-time high of $601.00 thousand, reached on November 30, 2019.
Performance
NRIX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$48.75 M
-$6.57 M-15.59%
November 30, 2024
Summary
- As of February 8, 2025, NRIX quarterly cash flow from operations is -$48.75 million, with the most recent change of -$6.57 million (-15.59%) on November 30, 2024.
- Over the past year, NRIX quarterly CFO has dropped by -$6.80 million (-16.21%).
- NRIX quarterly CFO is now -218.99% below its all-time high of $40.97 million, reached on February 29, 2020.
Performance
NRIX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$172.58 M
-$75.44 M-77.66%
November 30, 2024
Summary
- As of February 8, 2025, NRIX TTM cash flow from operations is -$172.58 million, with the most recent change of -$75.44 million (-77.66%) on November 30, 2024.
- Over the past year, NRIX TTM CFO has dropped by -$97.72 million (-130.53%).
- NRIX TTM CFO is now -521.22% below its all-time high of $40.97 million, reached on February 29, 2020.
Performance
NRIX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NRIX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -112.1% | -16.2% | -130.5% |
| 3 y3 years | -104.6% | -0.6% | -4.2% |
| 5 y5 years | -10000.0% | -0.6% | -4.2% |
NRIX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -112.1% | at low | -282.7% | at low | -130.5% | at low |
| 5 y | 5-year | <-9999.0% | at low | -219.0% | at low | -521.2% | at low |
| alltime | all time | <-9999.0% | at low | -219.0% | at low | -521.2% | at low |
Nurix Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | -$172.58 M(+112.1%) | -$48.75 M(+15.6%) | -$172.58 M(+77.7%) |
| Aug 2024 | - | -$42.18 M(+6.2%) | -$97.14 M(+1.1%) |
| May 2024 | - | -$39.70 M(-5.4%) | -$96.10 M(+28.4%) |
| Feb 2024 | - | -$41.95 M(-257.2%) | -$74.86 M(-8.0%) |
| Nov 2023 | -$81.36 M(-49.1%) | $26.69 M(-164.9%) | -$81.36 M(-44.3%) |
| Aug 2023 | - | -$41.13 M(+122.7%) | -$146.01 M(-3.4%) |
| May 2023 | - | -$18.47 M(-61.9%) | -$151.18 M(-8.7%) |
| Feb 2023 | - | -$48.45 M(+27.7%) | -$165.63 M(+3.6%) |
| Nov 2022 | -$159.81 M | -$37.95 M(-18.0%) | -$159.81 M(+4.6%) |
| Aug 2022 | - | -$46.31 M(+40.7%) | -$152.76 M(+12.0%) |
| May 2022 | - | -$32.91 M(-22.8%) | -$136.43 M(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2022 | - | -$42.63 M(+37.9%) | -$135.05 M(+60.1%) |
| Nov 2021 | -$84.36 M(>+9900.0%) | -$30.91 M(+3.1%) | -$84.36 M(+14.1%) |
| Aug 2021 | - | -$29.97 M(-5.0%) | -$73.94 M(+47.6%) |
| May 2021 | - | -$31.54 M(-491.6%) | -$50.10 M(+51.8%) |
| Feb 2021 | - | $8.05 M(-139.3%) | -$33.00 M(>+9900.0%) |
| Nov 2020 | -$80.00 K(-113.3%) | -$20.48 M(+233.5%) | -$80.00 K(-100.4%) |
| Aug 2020 | - | -$6.14 M(-57.4%) | $20.40 M(-23.1%) |
| May 2020 | - | -$14.43 M(-135.2%) | $26.54 M(-35.2%) |
| Feb 2020 | - | $40.97 M | $40.97 M |
| Nov 2019 | $601.00 K(-101.9%) | - | - |
| Nov 2018 | -$31.68 M | - | - |
FAQ
- What is Nurix Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Nurix Therapeutics?
- What is Nurix Therapeutics annual CFO year-on-year change?
- What is Nurix Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly CFO year-on-year change?
- What is Nurix Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Nurix Therapeutics?
- What is Nurix Therapeutics TTM CFO year-on-year change?
What is Nurix Therapeutics annual cash flow from operations?
The current annual CFO of NRIX is -$172.58 M
What is the all time high annual CFO for Nurix Therapeutics?
Nurix Therapeutics all-time high annual cash flow from operations is $601.00 K
What is Nurix Therapeutics annual CFO year-on-year change?
Over the past year, NRIX annual cash flow from operations has changed by -$91.22 M (-112.11%)
What is Nurix Therapeutics quarterly cash flow from operations?
The current quarterly CFO of NRIX is -$48.75 M
What is the all time high quarterly CFO for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly cash flow from operations is $40.97 M
What is Nurix Therapeutics quarterly CFO year-on-year change?
Over the past year, NRIX quarterly cash flow from operations has changed by -$6.80 M (-16.21%)
What is Nurix Therapeutics TTM cash flow from operations?
The current TTM CFO of NRIX is -$172.58 M
What is the all time high TTM CFO for Nurix Therapeutics?
Nurix Therapeutics all-time high TTM cash flow from operations is $40.97 M
What is Nurix Therapeutics TTM CFO year-on-year change?
Over the past year, NRIX TTM cash flow from operations has changed by -$97.72 M (-130.53%)